Immuneel eyes West Asia, Asia-Pacific expansion for cancer therapy after ₹100 crore funding
Published on: June 8, 2026, 7:15 p.m. | Source: Livemint
The company says its lower-cost treatment could help it compete in emerging markets across West Asia and Asia-Pacific.
